Akero Therapeutics (AKRO) Tops Q2 EPS by 1c
Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.60), $0.01 better than the analyst estimate of ($0.61).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.
Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.60), $0.01 better than the analyst estimate of ($0.61).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.